News

InflaRx Engages with Investors at Key Upcoming Conferences

InflaRx Engages with Investors at Key Upcoming Conferences

InflaRx N.V. Welcomes Investor Engagement in Upcoming Summits

InflaRx N.V. (Nasdaq: IFRX), a leading biopharmaceutical company based in Germany, is gearing up to take part in several noteworthy investor conferences this summer. As a trailblazer in developing innovative therapeutics aimed at combating inflammation by targeting the complement system, InflaRx is poised to showcase its advancements and connect with potential investors.

Jeffries Global Healthcare Conference

The company is set to participate in the prestigious Jefferies Global Healthcare Conference happening shortly. This event will occur from June 3rd to June 5th. As part of this gathering, InflaRx will host an investor presentation on June 4th at 7:35 AM ET. The presentation aims to share insights into the company’s strategic direction and innovations in the biopharmaceutical landscape. After the presentation, there will be opportunities for one-on-one investor meetings, highlighting InflaRx's commitment to fostering direct relationships with its investors.

Oppenheimer Innovators in I&I Summit

Continuing its proactive engagement with the investment community, InflaRx will also appear at the Oppenheimer Innovators in Inflammation and Immunology Summit. Scheduled for June 25th, this summit will feature InflaRx on a panel discussing recent advancements in dermatology, specifically focusing on atopic dermatitis (AD) and chronic spontaneous urticaria (CSU). This panel is expected to take place from 10:45 to 11:20 AM ET, providing a platform for InflaRx to demonstrate its pivotal role in developing solutions for these challenging conditions.

Leerink Partners Therapeutics Forum

Another significant event on InflaRx’s calendar is the Leerink Partners Therapeutics Forum, which focuses on inflammation and metabolism. This event is set for July 8th and 9th. In addition to networking with other industry leaders, the company will participate in individual meetings with investors on July 8th. Both events are created to foster deep discussions and engagement with potential stakeholders, allowing InflaRx to present its cutting-edge product pipeline.

About InflaRx N.V.

InflaRx N.V. is at the forefront of biopharmaceutical innovation with a focus on anti-inflammatory therapies. Utilizing its proprietary technologies, the company is dedicated to developing targeted treatments that address the complement activation factor C5a and its receptor, C5aR. This area of research is crucial, as C5a is recognized as a significant factor in the progression of various inflammatory diseases.

The company’s flagship product, vilobelimab, stands out as a first-in-class, intravenously administered monoclonal antibody. This innovative treatment selectively binds to the free C5a protein and has shown promising disease-modifying capabilities along with a favorable safety profile in numerous clinical trials. Furthermore, InflaRx is advancing its small molecule treatment, INF904, which offers a novel oral administration option for patients.

Founded in 2007, InflaRx N.V. maintains offices in both Germany and the United States, solidifying its international presence and dedication to enhancing patient health worldwide. For those eager to learn more about InflaRx and its initiatives, more information is available through their official resources.

Contact Information

InflaRx N.V.
Jan Medina, CFA
Vice President, Head of Investor Relations
Email: IR@inflarx.de

MC Services AG
Katja Arnold, Laurie Doyle, Dr. Regina Lutz
Email: inflarx@mc-services.eu
Europe: +49 89-210 2280
U.S.: +1-339-832-0752

Frequently Asked Questions

What is InflaRx N.V. known for?

InflaRx N.V. specializes in developing innovative anti-inflammatory therapies targeting the complement system.

When will InflaRx present at the investor conferences?

InflaRx will present on June 4th at the Jefferies Global Healthcare Conference and participate in various meetings.

What is vilobelimab?

Vilobelimab is InflaRx's lead product candidate, an intravenous monoclonal antibody targeting free C5a to treat inflammatory diseases.

Where are InflaRx’s offices located?

InflaRx has offices in Jena and Munich, Germany, and Ann Arbor, Michigan, USA.

How can I get in touch with InflaRx?

Interested parties can contact InflaRx through their investor relations email or the provided contact details for further inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Subaru, Motorq Offer Hardware-Free Fleet Telematics Insights

Updated Category News Views 4

An Unplugged Move in Fleet Management There's something brewing between Motorq and Subaru that could shake up fleet operations in ways most haven't thought possible yet. We’re talking about cutting those pesky hardware cords and diving straight into a future that's software-driven—and hey, we're all here for it. Direct, Data-Driven Leadership Imagine you're a fleet...

Continue Reading
Microplastics Webinar: Navigating Complex Regulations

Updated Category News Views 5

Buckle up, folks. The plastics debate is where regulatory battles and environmental concerns collide, and big changes are on the horizon. Let's talk about Bergeson & Campbell's latest shindig: "Plastics and Policy: Microplastics, EPR, and Other Emerging Trends"—a free-to-join webinar aiming to lift the lid on what's brewing beneath the surface of regulatory waters. The...

Continue Reading
Starr Conspiracy Unveils AI Tool for B2B Tech Firms

Updated Category News Views 5

AI-Driven Insight in Minutes: A Game Changer for B2B Hold onto your hats, because The Starr Conspiracy just lit a fire in the B2B tech world with its latest offering—Battle Card Builder. This free tool cranks out competitive intelligence in no time, literally about four minutes. Geared specifically for B2B tech marketing and sales teams, it combines decades of know-how...

Continue Reading
Spotlight on AI-Powered Smart Homes for 2027

Updated Category News Views 6

Gearing Up for the Connected Home Revolution Ah, the thrill of peering into the future of smart homes! That's what's cookin' as Parks Associates gears up for its annual CONNECTIONS™ Conference slated for May 4-6, 2027. This isn't just another routine pow-wow. Nope, this get-together is about seeing who's leading the pack in transforming our everyday spaces into...

Continue Reading
Retirement Security Faces Global Headwinds in 2026

Updated Category News Views 10

Grappling with an Uncertain Retirement Future Welcome to the 2026 Global Retirement Index (GRI), where it seems we're all being told to brace for a rough retirement ride. This year's results, crafted by Natixis Investment Managers and their pals at CoreData Research, spotlight just how shaky the ground has gotten. The core troublemakers? Aging populations, whopping public...

Continue Reading
Brands Must Choose: Cost or Value Leadership?

Updated Category News Views 6

Navigating the Business Jungle: Strategic Choices Unveiled If you've ever found yourself tangled in a web of corporate doublespeak, then you'll nod along with this: all those lofty brand management strategies often boil down to a fight over dollars or dizzying customer satisfaction. What's the winning play? According to Info-Tech Research Group, it's about firmly standing...

Continue Reading
New Podcast by Paralyzed Veterans of America Offers Unique Insights

Updated Category News Views 5

Empowering Veterans Through Storytelling Some stories don't just rattle around in your headphones—they stick with you. The 'Voices of PVA' podcast, launched by Paralyzed Veterans of America, aims to do exactly that. It's not just a podcast; it's a platform where voices of veterans and people with spinal cord injuries like MS and ALS aren't just heard, they're amplified....

Continue Reading
illycaffè's B Corp™ Recertification Reflects Bold Commitment

Updated Category News Views 3

illycaffè Hits Milestone with B Corp™ Recertification In an era where corporate responsibility isn't just fodder for feel-good presentations, illycaffè has proven it’s not just paying lip service to the idea. The Italian coffee titan has secured its B Corp™ recertification under snazzier, sharper V2 standards. This isn't just a shiny sticker to slap on marketing...

Continue Reading
PostalAnnex Lands at Stanford with New Service Hub

Updated Category News Views 4

PostalAnnex Makes a Strategic Stanford Move It's not every day you see a company nestling into a place like Stanford University. Annex Brands has just opened its latest PostalAnnex location, a stone’s throw from the academic hustle and bustle of the Stanford campus. The geeky vibe of students and professors rushing with deadlines matches well with the efficient service...

Continue Reading
NSF Backs New Space Projects: Cooling & Drug Delivery

Updated Category News Views 4

You know, every time we think we're at the edge of current science, space reminds us how little we actually know. From the International Space Station up there in low Earth orbit, fresh experiments are kicking off to change what we understand about electronics cooling and drug delivery. It's a classic scenario of reaching for the stars to help us out back here on Earth....

Continue Reading

Top 5 Most Recently Viewed Articles

Salesforce Boosts Data Management with Zoomin Acquisition

Updated Category News Views 166

Salesforce Expands with Its Latest Zoomin Acquisition Salesforce.com (NYSE: CRM) is making waves in the market as it maintains its Sector Weight rating following the acquisition of Zoomin, a firm that focuses on managing unstructured data. This move is viewed as a strategic opportunity to strengthen Salesforce's Data Cloud initiatives, integral to the broader Agentforce...

Continue Reading
Unlocking Value: The AI Fund with a 7.9% Dividend Yield

Updated Category News Views 133

Unlocking Value with a 7.9% Yield There's an exciting opportunity in the world of AI dividends that's currently presenting a remarkable yield of 7.9%. The recent fluctuations in the stock market have made this gem even more appealing, but the real treasure has been hiding right under our noses for some time. It's essential to act swiftly because this opportunity may not...

Continue Reading
XPLR Infrastructure Prepares for Q3 2025 Financial Meeting

Updated Category News Views 196

XPLR Infrastructure's Financial Reporting Schedule XPLR Infrastructure, LP (NYSE: XIFR) recently provided an update regarding its third-quarter financial results. The company will announce these results after the market closes on November 4, 2025. Investors and interested parties will find a comprehensive news release posted directly on the company's official website....

Continue Reading
Key Insights on NTG Nordic Transport Group’s Upcoming AGM

Updated Category News Views 150

NTG Nordic Transport Group A/S Annual General Meeting Details NTG Nordic Transport Group A/S is gearing up for an important event in its corporate calendar, the Annual General Meeting (AGM). This pivotal meeting provides shareholders a chance to engage with the company's operations and governance. It is scheduled for a Friday afternoon, specifically on March 28, 2025. A...

Continue Reading
Inflation Worries Persist as Fed Implements Rate Cuts

Updated Category News Views 100

Inflation Worries Amid Federal Reserve Rate Cuts As monetary policy undergoes significant changes, the tension between controlling inflation and supporting employment is growing. The Federal Reserve has launched a cycle of rate cuts, raising fresh concerns among investors about the potential for inflation in the U.S. bond market. As the Fed shifts its priorities, many are...

Continue Reading